Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2025 Aug;1871(6):167842.
doi: 10.1016/j.bbadis.2025.167842. Epub 2025 Apr 11.

Proteome alterations in peripheral immune cells of DLBCL patients and evidence of cancer extracellular vesicles involvement

Mostafa Ejtehadifar  1 , Sara Zahedi  1 , Paula Gameiro  2 , José Cabeçadas  2 , Manuel S Rodriguez  3 , Maria Gomes da Silva  2 , Hans Christian Beck  4 , Rune Matthiesen  5 , Ana Sofia Carvalho  6
Affiliations
Free article

Proteome alterations in peripheral immune cells of DLBCL patients and evidence of cancer extracellular vesicles involvement

Mostafa Ejtehadifar et al. Biochim Biophys Acta Mol Basis Dis. 2025 Aug.
Free article

Abstract

Diffuse large B-cell lymphoma (DLBCL) is an aggressive disease and a frequent form of non-Hodgkin lymphoma. Given the primary localization of DLBCL and the effect of tumors on the systemic immune response, we investigated the proteome of DLBCL patients' and healthy donors (HDs') peripheral immune cells (PICs). Since the ubiquitin-proteasome system has a vital role in proteome regulation and immune cells' functions, this study also explores the potential impact of DLBCL secretome on the polyubiquitination level in PICs. PICs from DLBCL patients and HDs were isolated and analyzed by mass spectrometry-based proteomics. The analysis resulted in 135 down and 51 upregulated proteins (adjusted p-value <0.05). Unsupervised principal component analysis revealed distinct proteomic profiles between DLBCL and HDs. Functional enrichment analysis for comparison between DLBCL and HDs-PICs proteome identified immune-related pathways such as innate immune system, specifically neutrophil degranulation, Fcγ receptor-dependent phagocytosis, and JAK-STAT signaling after IL-12 stimulation as downregulated. Proteomics analysis of DLBCL-PICs also showed dysregulation of proteostasis factors. This prompted the investigation of the effect of tumor secretome on viability and polyubiquitination level in mononuclear immune cells. Therefore, human HD peripheral blood mononuclear cells (PBMCs) were cultured in the presence of DLBCL cell line-derived soluble factors, small-EVs, and large-EVs in vitro. Our results revealed that exposure of mainly small-EVs, and large-EVs to HD PBMCs increased the polyubiquitination in PBMCs and decreased PIC viability. These findings suggest impaired immune responses in DLBCL-PICs, with tumor secretome-inducing polyubiquitination and reduced PIC viability.

Keywords: Diffuse large B cell lymphoma; Extracellular vesicles; Peripheral immune cells; Polyubiquitination; Proteomics.

PubMed Disclaimer

Conflict of interest statement

Declaration of competing interest The authors declare the following financial interests/personal relationships which may be considered as potential competing interests: Ana Sofia Carvalho and Rune Matthiesen reports financial support, article publishing charges, and equipment, drugs, or supplies were provided by Fundação para a Ciência e a Tecnologia. Rune Matthiesen reports financial support was provided by Horizon 2020. If there are other authors, they declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

MeSH terms

LinkOut - more resources